We may earn if you use our links. details
FORECASTEDNationwide

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Type 1 diabetes (T1D) is a complex disease involving interactions among many different cell types, tissues, organs and biological processes. Genetics, the environment, and lifestyle all play a role in disease development and progression. Over the past two decades, the National Institute of Diabetes

Plain-language brief

What this opportunity funds

Type 1 diabetes (T1D) is a complex disease involving interactions among many different cell types, tissues, organs and biological processes. Genetics, the environment, and lifestyle all play a role in disease development and progression. Over the past two decades, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has supported major T1D research consortia covering basic, translational, and clinical research. Each consortium has focused on different aspects of T1D, such as specific organs, stages of disease or clinical outcomes. Together, these consortia have collected large longitudinal and multimodal datasets using standardized protocols and coordinated studies. While individual consortia have improved our understanding of specific areas, combining their work offers a rare opportunity to see how different biological processes interact to drive T1D development and progression. This integrated view can answer fundamental questions about T1D biology that cannot be answered using individual datasets or studies alone. Recent advances in artificial intelligence (AI) now make it possible to integrate these complementary datasets and study T1D across various tissues, disease stages, and biological levels. Building on these resources, NIDDK will support a coordinated, milestone-driven research project to answer fundamental questions about T1D biology and accelerate the development of personalized medicine. The project will combine multimodal human pancreas and clinical datasets to better understand how biological processes interact as T1D develops and progresses. The research will generate new insights into T1D biology, help us understand the different forms and stages of T1D, identify biomarkers, and inform new approaches for disease prevention, intervention, and treatment. To support the research, the project will develop and test advanced multimodal AI models. It will also develop AI-enabled research workflows, new methods to integrate data, and privacy-preserving synthetic datasets.

Eligibility at a glance

Eligible applicants
Independent school districts, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Public and State controlled institutions of higher education, Special district governments, Private institutions of higher education, State governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, County governments, Small businesses, City or township governments, For profit organizations other than small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification), Native American tribal organizations (other than Federally recognized tribal governments)
Eligible locations
Eligible applicants across the United States
Eligible activities
Health
Matching requirement
Not specified
Registration
SAM.gov, Grants.gov

Application process

  1. Read the complete official notice and confirm every eligibility rule.
  2. Complete required registrations early; federal registrations can take time.
  3. Build the budget, work plan, evidence, and attachments requested by the sponsor.
  4. Submit through the official portal and retain the confirmation.

Change history

No material changes have been recorded since this opportunity entered the hub.

Related opportunities

FORECASTEDNationwide

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

National Institutes of Health

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregna

Award
Amount not specified
Deadline
Not specified
Intermediary grantFor profit organizations other than small businessesIntermediary / support
source verifiedVerified Aug 21, 2026
FORECASTEDNationwide

Partnership with Common Fund Data Ecosystem Resources

National Institutes of Health

The NIH Office of Strategic Coordination (Common Fund) has generated many valuable and widely available datasets. The Common Fund Data Ecosystem is helping to ensure that all Common Fund (CF) data are Findable, Accessible, Interoperable, and Reusable (FAIR). The purpose of this Notice of Funding Opp

Award
Up to $1,200,000
Deadline
Not specified
Intermediary grantCity or township governmentsIntermediary / support
source verifiedVerified Aug 7, 2026
FORECASTEDNationwide

RNomics Molecular Standards

National Institutes of Health

The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies an

Award
Amount not specified
Deadline
Not specified
Intermediary grantNative American tribal organizations (other than Federally recognized tribal governments)Intermediary / support
source verifiedVerified Aug 6, 2026